Go to Page # Page of 45

Futurescan 2017–2022 Big Data in Healthcare

 Kenneth Kaufman, Michael E. Chernew PhD, Shahram Ehadollahi PhD, Howard R. Grant MD, Maureen A. Biso
Description: For healthcare organizations to succeed in the changing landscape, they will need new capabilities that require the scale and resources that come with integration and consolidation. Hospital and health system consolidations continue at a rapid pace. Chain pharmacies are gaining more influence over the provision of care.
Views: 1161
Domain: Medical
Category: Practice Mngmnt
weSRCH App on Apple
Futurescan 2017–2022 contributors:

Kenneth Kaufman, Chairman, Kaufman, Hall &
Associates, LLC

Michael E. Chernew, PhD, Professor of Health Care
Policy, Harvard Medical School

Shahram Ehadollahi, PhD, Vice President of
Innovations and Chief Science Officer, IBM Watson

Howard R. Grant, MD, JD, President and CEO, Lahey

Maureen A. Bisogn ... See more

Recent Presentations

Novel Checkpoints in Immuno-Oncology

This document has been prepared by Innate Pharma S.A. (the “Company”) solely for the purposes of a presentation to investors concerning the Company. This document is not to be repr

19 March, 2018

Oncolytic Immunotherapeutics Leadership

The presentation and the accompanying oral commentary contain forward-looking statements within the meaning of the relevant securities laws of the Republic of Korea and the United

SillaJen Inc
18 March, 2018

Basket and Umbrella Trial Designs in Oncology

Historically, phase I conducted with mixture of solid tumors, then phase II and III oncology trials were histopathologic focused (e.g. lung cancer study, breast cancer study, etc.)

Eric Polley
17 March, 2018